Katy Rezvani, M.D., Ph.D
@lab_rezvani
Vice President & Head, Institute of Cell Therapy Discovery & Innovation, MD Anderson Cancer Center
ID: 1223726418284118017
https://faculty.mdanderson.org/profiles/katy_rezvani.html 01-02-2020 21:55:10
304 Tweet
4,4K Takipçi
540 Takip Edilen
Please check out our paper published in Nature Medicine on our Phase I / II trial with cord blood CAR19/IL15 NK cells. We report promising 1 year PF and OS rates of 32% and 68% in patients with relapsed / refractory B cell malignancies (with a median of 4 prior lines of